Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) Director Keith M. Gehl purchased 1,000 shares of Kewaunee Scientific stock in a transaction dated Friday, April 4th. The shares were purchased at an average price of $35.00 per share, with a total value of $35,000.00. Following the completion of the acquisition, the director now owns 18,500 shares in the company, valued at $647,500. The trade was a 5.71 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Kewaunee Scientific Stock Up 1.1 %
Kewaunee Scientific stock opened at $36.06 on Tuesday. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 1-year low of $30.82 and a 1-year high of $71.33. The firm's fifty day simple moving average is $52.97 and its 200-day simple moving average is $47.47. The company has a market capitalization of $102.95 million, a P/E ratio of 5.71 and a beta of 0.59.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%. The company had revenue of $67.17 million for the quarter.
Analyst Ratings Changes
Separately, StockNews.com lowered shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.
Get Our Latest Research Report on KEQU
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the stock. State Street Corp acquired a new position in Kewaunee Scientific during the third quarter valued at approximately $266,000. Barclays PLC bought a new stake in shares of Kewaunee Scientific during the 3rd quarter worth $121,000. Geode Capital Management LLC boosted its holdings in shares of Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock worth $792,000 after buying an additional 1,941 shares during the period. JPMorgan Chase & Co. grew its stake in Kewaunee Scientific by 18,000.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock valued at $30,000 after buying an additional 900 shares during the last quarter. Finally, Ritholtz Wealth Management raised its holdings in Kewaunee Scientific by 15.6% in the 4th quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company's stock worth $781,000 after acquiring an additional 1,706 shares during the period. 32.69% of the stock is owned by institutional investors.
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
